Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Originally published as Ann Surg Oncol Early Release 10.1245/ASO.2004.03.053 on December 8, 2003

Annals of Surgical Oncology 11:27-33 (2004)
© 2004 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez, M. J.
Right arrow Articles by Luna-Pérez, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez, M. J.
Right arrow Articles by Luna-Pérez, P.
Related Collections
Right arrow Surgery
Right arrow Radiation Therapy

ORIGINAL ARTICLES

Composite Pelvic Exenteration: Is It Worthwhile?

Marvin J. Lopez, MD, FACS, FRCSC and Pedro Luna-Pérez, MD

From the Department of Surgery, Division of Surgical Oncology (MJL), St. Elizabeth’s Medical Center and Tufts University School of Medicine, Boston, MA; and Colorectal Service, Surgical Oncology Department (PL-P), Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México.

Correspondence: Address correspondence and reprint requests to: Marvin J. Lopez, MD, St. Elizabeth’s Medical Center of Boston, 736 Cambridge Street, CMPI, Boston, MA 02135–2997; Fax: 617-789-3433; E-mail: marvin_lopez_md{at}cchcs.org

Background: In locally advanced pelvic cancer, tumor fixation to the bony pelvis is regarded as unresectable and often inoperable. Few data exist regarding the futility or utility of pelvic exenteration with en bloc resection of involved portions of the bony pelvis.

Methods: Thirty-four of 625 patients undergoing radical pelvic procedures had an en bloc resection of pelvic organs with portions of the bony pelvis. There were 19 female and 15 male patients, and the median age was 59 years. Primary neoplasms included 19 rectal, 6 cervicouterine, 4 anal, 3 vaginal, 1 sarcoma, and 1 penile. All but three patients underwent preoperative pelvic irradiation. Pelvic exenterations were posterior in 7 patients, anterior in 3, supralevator in 3, and total in 21 patients. Pelvic bony resections included portions of the sacrum-coccyx in 18 patients, ischium in 5, pubic symphysis in 4, and ischial pubic rami in 4, and hemipelvectomy was performed in 3.

Results: Surgical morbidity occurred in 67.6% (23) of 24 patients. Median follow-up was 37 months. Pelvic or perineal tumor recurrence was concurrent with distant metastases in 9 patients (26.4%); 6 (17.6%) had only distant relapse, and 2 (5.8%) died with local recurrence alone. Overall cancer-related mortality rate was 50%. Five-year overall and cancer-specific survival rates were 44% and 52%, respectively.

Conclusions: Substantial survival can be accomplished for patients whose tumors are fixed to limited portions of the bony pelvis. These procedures are still associated with substantial morbidity, but operative mortality is infrequent.

Key Words: Anal canal cancer • Gynecological cancer • Radiotherapy • Pelvic exenteration • Rectal cancer







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society of Surgical Oncology.